Genetic thrombophilias and intrauterine growth restriction: A meta-analysis

Obstetrics and Gynecology

Volumn 113, Issue 6, 2009, Pages 1206-1216

  Facco, Francesca ^a,b   You, Whitney ^a   Grobman, William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN; BLOOD CLOTTING FACTOR 5; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ARTICLE; COHORT ANALYSIS; DISEASE ASSOCIATION; GENE MUTATION; GENETIC DISORDER; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRAUTERINE GROWTH RETARDATION; PRIORITY JOURNAL; THROMBOPHILIA; FEMALE; GENETICS; META ANALYSIS; PREGNANCY;

FACTOR V; FEMALE; FETAL GROWTH RETARDATION; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PREGNANCY; PROTHROMBIN; THROMBOPHILIA;

EID: 67649388381     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181a6e96a     Document Type: Article

References (48)

1. American College of Obstetricians and Gynecologists Intrauterine growth restriction. ACOG Practice Bulletin 12. Reaffirmed 2008. Washington (DC): ACOG; 2000.
2. Druzin ML, Gratacos J, Keegan KA, Paul RH. Antepartum fetal heart rate testing. VII. The significance of fetal bradycardia. Am J Obstet Gynecol 1981;139 194-8.
3. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999;340:1234-8.
4. Strauss RS. Effects of the intrauterine environment on childhood growth. Br Med Bull 1997;53:81-95.
5. Strauss RS, Dietz WH. Effects of intrauterine growth retardation in premature infants on early childhood growth. J Pediatr 1997;130:95-102.
6. Barker DJ. Fetal origins of cardiovascular disease. Ann Med 1999;31 suppl:3-6.
7. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ. Weight in infancy and death from ischaemic heart disease. Lancet 1989;2:577-80.
8. Strauss RS, Dietz WH. Growth and development of term children born with low birth weight: effects of genetic and environmental factors. J Pediatr 1998;133:67-72.
9. Spinillo A, Capuzzo E, Nicola SE, Colonna L, Egbe TO, Zara C. Factors potentiating the smoking-related risk of fetal growth retardation. Br J Obstet Gynaecol 1994;101:954-8.
10. Shu XO, Hatch MC, Mills J, Clemens J, Susser M. Maternal smoking, alcohol drinking, caffeine consumption, and fetal growth: results from a prospective study. Epidemiology 1995; 6:115-20.
11. Lieberman E, Gremy I, Lang JM, Cohen AP. Low birthweight at term and the timing of fetal exposure to maternal smoking. Am J Public Health 1994;84:1127-31.
12. Nieto A, Matorras R, Serra M, Valenzuela P, Molero J. Multivariate analysis of determinants of fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1994;53:107-13.
13. Preston FE, Rosendaal FR, Walker ID, Brië t E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
14. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart-Neveu S, Tailland ML, et al. Case control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic antecedent-the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 1999;81:891-9.
15. Agorastos T, Karavida A, Lambropoulos A, Constantinidis T, Tzitzimikas S, Chrisafi S, et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med 2002;12:267-73.
16. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel G Jr, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-24.
17. Franchi F, Cetin I, Todros T, Antonazzo P, Nobile de Santis MS, Cardaropoli S, et al. Intrauterine growth restriction and genetic predisposition to thrombophilia. Haematologica 2004; 89:444-9.
18. Infante-Rivard C, Rivard GE, Yotov WV, Ge'nin E, Guiguet M, Weinberg C, et al. Absence of association of thrombophilia polymorphisms with intrauterine growth restriction. N Engl J Med 2002;347:19-25.
19. Jarvenpaa J, Pakkila M, Savolainen ER, Perheentupa A, Jarvela I, Ryynanen M. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene muta- tions in patients with severe pregnancy complications in northern Finland. Gynecol Obstet Invest 2006;62:28-32.
20. Karakantza M, Androutsopoulos G, Mougiou A, Sakellaropoulos G, Kourounis G, Decavalas G. Inheritance and perinatal consequences of inherited thrombophilia in Greece. Int J Gynaecol Obstet 2008;100:124-9.
21. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy [published erratum appears in N Engl J Med 1999;341:384]. N Engl J Med 1999;340:9-13.
22. Kupferminc MJ, Many A, Bar-Am A, Lessing JB, Ascher- Landsberg J. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. BJOG 2002;109:1373-6.
23. Lindqvist PG, Svensson PJ, Marsaal K, Grennert L, Luterkort M, Dahlback B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost 1999;81:532-7.
24. Martinelli P, Grandone E, Colaizzo D, Pavone G, Paladini D, Martinelli P, et al. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica 2001;86:428-31.
25. McCowan LM, Craigie S, Taylor RS, Ward C, McLintock C, North RA. Inherited thrombophilias are not increased in "idiopathic" small-for-gestational-age pregnancies. Am J Obstet Gynecol 2003;188:981-5.
26. Murphy RP, Donoghue C, Nallen RJ, D'Mello M, Regan C, Whitehead AS, et al. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy. Arterioscler Thromb Vasc Biol 2000;20:266-70.
27. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Associations between maternal methylenetetrahydrofolate reductase polymorphisms and adverse outcomes of pregnancy: the Hordaland Homocysteine Study. Am J Med 2004;117:26-31.
28. Verspyck E, Borg JY, Le Cam-Duchez V, Goffinet F, Degre' S, Fournet P, et al. Thrombophilia and fetal growth restriction. Eur J Obstet Gynecol Reprod Biol 2004;113:36-40.
29. Zahed LF, Rayes RF, Mahfouz RA, Taher AT, Maarouf HH, Nassar AH. Prevalence of factor V Leiden, prothrombin and methylene tetrahydrofolate reductase mutations in women with adverse pregnancy outcomes in Lebanon. Am J Obstet Gynecol 2006;195:1114-8.
30. Stella CL, How HY, Sibai BM. Thrombophilia and adverse maternal-perinatal outcome: controversies in screening and management. Am J Perinatol 2006;23:499-506.
31. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-96.
32. Lockwood CJ. Inherited thrombophilias in pregnant patients. Prenat Neonat Med 2001;6:3-14.
33. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3=-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88: 3698-703.
34. van der Meer FJ, Koster T, Vandenbroucke JP, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997;78:631-5.
35. Takkouche B, Cadarso-Suarez C, Spiegelman D. Evaluation of old and new tests of heterogeneity in epidemiologic metaanalysis. Am J Epidemiol 1999;150:206-15.
36. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in metaanalysis. Biometrics 2000;56:455-63.
37. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on metaanalyses. BMJ 2000;320:1574-7.
38. Sutton AJ, Song F, Gilbody SM, Abrams KR. Modelling publication bias in meta-analysis: a review. Stat Methods Med Res 2000;9:421-45.
39. Dudding T, Heron J, Thakkinstian A, Nurk E, Golding J, Pembrey M, et al. Factor V Leiden is associated with preeclampsia but not with fetal growth restriction: a genetic association study and meta-analysis. J Thromb Haemost 2008; 6:1869-75.
40. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM 2006;99:289-98.
41. Özbek N, Atac FB, Verdi H, Cetintas S, Gurakan B, Haberal A. Relationship between small-for-gestational age births and maternal thrombophilic mutations. Thromb Res 2008;122: 175-8.
42. Stonek F, Hafner E, Philipp K, Hefler LA, Bentz EK, Tempfer CB. Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications. Obstet Gynecol 2007; 110:363-8.
43. Engel SM, Olshan AF, Siega-Riz AM, Savitz DA, Chanock SJ. Polymorphisms in folate metabolizing genes and risk for spontaneous preterm and small-for-gestational age birth. Am J Obstet Gynecol 2006;195:1231.e1-11.
44. Verspyck E, Le Cam-Duchez V, Goffinet F, Tron F, Marpeau L, Borg JY. Thrombophilia and immunological disorders in pregnancies as risk factors for small for gestational age infants. BJOG 2002;109:28-33.
45. Kupferminc MJ, Peri H, Zwang E, Yaron Y, Wolman I, Eldor A. High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester loss. Acta Obstet Gynecol Scand 2000;79:963-7.
46. Zollner S, Pritchard JK. Overcoming the winner's curse: estimating penetrance parameters from case- control data. Am J Hum Genet 2007;80:605-15.
47. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-82.
48. Hedges LV, Pigott TD. The power of statistical tests in meta-analysis. Psychol Methods 2001;6:203-17.